1 Introduction to Research & Analysis Reports
    1.1 Vaccines Administered Orally Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Vaccines Administered Orally Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Vaccines Administered Orally Overall Market Size
    2.1 Global Vaccines Administered Orally Market Size: 2021 VS 2027
    2.2 Global Vaccines Administered Orally Revenue, Prospects & Forecasts: 2016-2027
    2.3 Global Vaccines Administered Orally Sales (Consumption): 2016-2027
3 Company Landscape
    3.1 Top Vaccines Administered Orally Players in Global Market
    3.2 Top Global Vaccines Administered Orally Companies Ranked by Revenue
    3.3 Global Vaccines Administered Orally Revenue by Companies
    3.4 Global Vaccines Administered Orally Sales by Companies
    3.5 Global Vaccines Administered Orally Price by Manufacturer (2016-2021)
    3.6 Top 3 and Top 5 Vaccines Administered Orally Companies in Global Market, by Revenue in 2020
    3.7 Global Manufacturers Vaccines Administered Orally Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Vaccines Administered Orally Players in Global Market
        3.8.1 List of Global Tier 1 Vaccines Administered Orally Companies
        3.8.2 List of Global Tier 2 and Tier 3 Vaccines Administered Orally Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Vaccines Administered Orally Market Size Markets, 2021 & 2027
        4.1.2 Human
        4.1.3 Animal
    4.2 By Type - Global Vaccines Administered Orally Revenue & Forecasts
        4.2.1 By Type - Global Vaccines Administered Orally Revenue, 2016-2021
        4.2.2 By Type - Global Vaccines Administered Orally Revenue, 2022-2027
        4.2.3 By Type - Global Vaccines Administered Orally Revenue Market Share, 2016-2027
    4.3 By Type - Global Vaccines Administered Orally Sales & Forecasts
        4.3.1 By Type - Global Vaccines Administered Orally Sales, 2016-2021
        4.3.2 By Type - Global Vaccines Administered Orally Sales, 2022-2027
        4.3.3 By Type - Global Vaccines Administered Orally Sales Market Share, 2016-2027
    4.4 By Type - Global Vaccines Administered Orally Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Vaccines Administered Orally Market Size, 2021 & 2027
        5.1.2 Public
        5.1.3 Private
    5.2 By Application - Global Vaccines Administered Orally Revenue & Forecasts
        5.2.1 By Application - Global Vaccines Administered Orally Revenue, 2016-2021
        5.2.2 By Application - Global Vaccines Administered Orally Revenue, 2022-2027
        5.2.3 By Application - Global Vaccines Administered Orally Revenue Market Share, 2016-2027
    5.3 By Application - Global Vaccines Administered Orally Sales & Forecasts
        5.3.1 By Application - Global Vaccines Administered Orally Sales, 2016-2021
        5.3.2 By Application - Global Vaccines Administered Orally Sales, 2022-2027
        5.3.3 By Application - Global Vaccines Administered Orally Sales Market Share, 2016-2027
    5.4 By Application - Global Vaccines Administered Orally Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
    6.1 By Region - Global Vaccines Administered Orally Market Size, 2021 & 2027
    6.2 By Region - Global Vaccines Administered Orally Revenue & Forecasts
        6.2.1 By Region - Global Vaccines Administered Orally Revenue, 2016-2021
        6.2.2 By Region - Global Vaccines Administered Orally Revenue, 2022-2027
        6.2.3 By Region - Global Vaccines Administered Orally Revenue Market Share, 2016-2027
    6.3 By Region - Global Vaccines Administered Orally Sales & Forecasts
        6.3.1 By Region - Global Vaccines Administered Orally Sales, 2016-2021
        6.3.2 By Region - Global Vaccines Administered Orally Sales, 2022-2027
        6.3.3 By Region - Global Vaccines Administered Orally Sales Market Share, 2016-2027
    6.4 North America
        6.4.1 By Country - North America Vaccines Administered Orally Revenue, 2016-2027
        6.4.2 By Country - North America Vaccines Administered Orally Sales, 2016-2027
        6.4.3 US Vaccines Administered Orally Market Size, 2016-2027
        6.4.4 Canada Vaccines Administered Orally Market Size, 2016-2027
        6.4.5 Mexico Vaccines Administered Orally Market Size, 2016-2027
    6.5 Europe
        6.5.1 By Country - Europe Vaccines Administered Orally Revenue, 2016-2027
        6.5.2 By Country - Europe Vaccines Administered Orally Sales, 2016-2027
        6.5.3 Germany Vaccines Administered Orally Market Size, 2016-2027
        6.5.4 France Vaccines Administered Orally Market Size, 2016-2027
        6.5.5 U.K. Vaccines Administered Orally Market Size, 2016-2027
        6.5.6 Italy Vaccines Administered Orally Market Size, 2016-2027
        6.5.7 Russia Vaccines Administered Orally Market Size, 2016-2027
        6.5.8 Nordic Countries Vaccines Administered Orally Market Size, 2016-2027
        6.5.9 Benelux Vaccines Administered Orally Market Size, 2016-2027
    6.6 Asia
        6.6.1 By Region - Asia Vaccines Administered Orally Revenue, 2016-2027
        6.6.2 By Region - Asia Vaccines Administered Orally Sales, 2016-2027
        6.6.3 China Vaccines Administered Orally Market Size, 2016-2027
        6.6.4 Japan Vaccines Administered Orally Market Size, 2016-2027
        6.6.5 South Korea Vaccines Administered Orally Market Size, 2016-2027
        6.6.6 Southeast Asia Vaccines Administered Orally Market Size, 2016-2027
        6.6.7 India Vaccines Administered Orally Market Size, 2016-2027
    6.7 South America
        6.7.1 By Country - South America Vaccines Administered Orally Revenue, 2016-2027
        6.7.2 By Country - South America Vaccines Administered Orally Sales, 2016-2027
        6.7.3 Brazil Vaccines Administered Orally Market Size, 2016-2027
        6.7.4 Argentina Vaccines Administered Orally Market Size, 2016-2027
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Vaccines Administered Orally Revenue, 2016-2027
        6.8.2 By Country - Middle East & Africa Vaccines Administered Orally Sales, 2016-2027
        6.8.3 Turkey Vaccines Administered Orally Market Size, 2016-2027
        6.8.4 Israel Vaccines Administered Orally Market Size, 2016-2027
        6.8.5 Saudi Arabia Vaccines Administered Orally Market Size, 2016-2027
        6.8.6 UAE Vaccines Administered Orally Market Size, 2016-2027
7 Manufacturers & Brands Profiles
    7.1 Merck
        7.1.1 Merck Corporate Summary
        7.1.2 Merck Business Overview
        7.1.3 Merck Vaccines Administered Orally Major Product Offerings
        7.1.4 Merck Vaccines Administered Orally Sales and Revenue in Global (2016-2021)
        7.1.5 Merck Key News
    7.2 GSK
        7.2.1 GSK Corporate Summary
        7.2.2 GSK Business Overview
        7.2.3 GSK Vaccines Administered Orally Major Product Offerings
        7.2.4 GSK Vaccines Administered Orally Sales and Revenue in Global (2016-2021)
        7.2.5 GSK Key News
    7.3 Sanofi
        7.3.1 Sanofi Corporate Summary
        7.3.2 Sanofi Business Overview
        7.3.3 Sanofi Vaccines Administered Orally Major Product Offerings
        7.3.4 Sanofi Vaccines Administered Orally Sales and Revenue in Global (2016-2021)
        7.3.5 Sanofi Key News
    7.4 Lanzhou Institute
        7.4.1 Lanzhou Institute Corporate Summary
        7.4.2 Lanzhou Institute Business Overview
        7.4.3 Lanzhou Institute Vaccines Administered Orally Major Product Offerings
        7.4.4 Lanzhou Institute Vaccines Administered Orally Sales and Revenue in Global (2016-2021)
        7.4.5 Lanzhou Institute Key News
    7.5 Serum Institute
        7.5.1 Serum Institute Corporate Summary
        7.5.2 Serum Institute Business Overview
        7.5.3 Serum Institute Vaccines Administered Orally Major Product Offerings
        7.5.4 Serum Institute Vaccines Administered Orally Sales and Revenue in Global (2016-2021)
        7.5.5 Serum Institute Key News
    7.6 Valneva
        7.6.1 Valneva Corporate Summary
        7.6.2 Valneva Business Overview
        7.6.3 Valneva Vaccines Administered Orally Major Product Offerings
        7.6.4 Valneva Vaccines Administered Orally Sales and Revenue in Global (2016-2021)
        7.6.5 Valneva Key News
    7.7 Shanghai United Cell
        7.7.1 Shanghai United Cell Corporate Summary
        7.7.2 Shanghai United Cell Business Overview
        7.7.3 Shanghai United Cell Vaccines Administered Orally Major Product Offerings
        7.4.4 Shanghai United Cell Vaccines Administered Orally Sales and Revenue in Global (2016-2021)
        7.7.5 Shanghai United Cell Key News
    7.8 Bibcol
        7.8.1 Bibcol Corporate Summary
        7.8.2 Bibcol Business Overview
        7.8.3 Bibcol Vaccines Administered Orally Major Product Offerings
        7.8.4 Bibcol Vaccines Administered Orally Sales and Revenue in Global (2016-2021)
        7.8.5 Bibcol Key News
    7.9 PaxVax
        7.9.1 PaxVax Corporate Summary
        7.9.2 PaxVax Business Overview
        7.9.3 PaxVax Vaccines Administered Orally Major Product Offerings
        7.9.4 PaxVax Vaccines Administered Orally Sales and Revenue in Global (2016-2021)
        7.9.5 PaxVax Key News
    7.10 Vabiotech
        7.10.1 Vabiotech Corporate Summary
        7.10.2 Vabiotech Business Overview
        7.10.3 Vabiotech Vaccines Administered Orally Major Product Offerings
        7.10.4 Vabiotech Vaccines Administered Orally Sales and Revenue in Global (2016-2021)
        7.10.5 Vabiotech Key News
    7.11 Tiantan Biological
        7.11.1 Tiantan Biological Corporate Summary
        7.11.2 Tiantan Biological Vaccines Administered Orally Business Overview
        7.11.3 Tiantan Biological Vaccines Administered Orally Major Product Offerings
        7.11.4 Tiantan Biological Vaccines Administered Orally Sales and Revenue in Global (2016-2021)
        7.11.5 Tiantan Biological Key News
    7.12 EuBiologics
        7.12.1 EuBiologics Corporate Summary
        7.12.2 EuBiologics Vaccines Administered Orally Business Overview
        7.12.3 EuBiologics Vaccines Administered Orally Major Product Offerings
        7.12.4 EuBiologics Vaccines Administered Orally Sales and Revenue in Global (2016-2021)
        7.12.5 EuBiologics Key News
    7.13 Panacea Biotec Ltd
        7.13.1 Panacea Biotec Ltd Corporate Summary
        7.13.2 Panacea Biotec Ltd Vaccines Administered Orally Business Overview
        7.13.3 Panacea Biotec Ltd Vaccines Administered Orally Major Product Offerings
        7.13.4 Panacea Biotec Ltd Vaccines Administered Orally Sales and Revenue in Global (2016-2021)
        7.13.5 Panacea Biotec Ltd Key News
    7.14 Bio-Med
        7.14.1 Bio-Med Corporate Summary
        7.14.2 Bio-Med Business Overview
        7.14.3 Bio-Med Vaccines Administered Orally Major Product Offerings
        7.14.4 Bio-Med Vaccines Administered Orally Sales and Revenue in Global (2016-2021)
        7.14.5 Bio-Med Key News
    7.15 Halfkin Bio-Pharmaceuticals
        7.15.1 Halfkin Bio-Pharmaceuticals Corporate Summary
        7.15.2 Halfkin Bio-Pharmaceuticals Business Overview
        7.15.3 Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Major Product Offerings
        7.15.4 Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Sales and Revenue in Global (2016-2021)
        7.15.5 Halfkin Bio-Pharmaceuticals Key News
8 Global Vaccines Administered Orally Production Capacity, Analysis
    8.1 Global Vaccines Administered Orally Production Capacity, 2016-2027
    8.2 Vaccines Administered Orally Production Capacity of Key Manufacturers in Global Market
    8.3 Global Vaccines Administered Orally Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Vaccines Administered Orally Supply Chain Analysis
    10.1 Vaccines Administered Orally Industry Value Chain
    10.2 Vaccines Administered Orally Upstream Market
    10.3 Vaccines Administered Orally Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Vaccines Administered Orally Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer